Key points are not available for this paper at this time.
Dasatinib, an oral inhibitor of ABL and SRC family tyrosine kinases, is an effective drug for patients with Philadelphia chromosome positive (Ph+) leukemia, especially for those who develop resista...
Shimokaze et al. (Mon,) studied this question.